Aptean Launches AppCentral 2.0: The AI Platform Purpose-Built for Industries Addex Shareholders Approve All Resolutions at Annual General Meeting
Geneva, Switzerland, June 17, 2021 – Addex Therapeutics (SIX: ADXN), a clinical-stage pharmaceutical company pioneering…
Stellate Therapeutics Strengthens Senior Management Team
Stellate Therapeutics Strengthens Senior Management Team David Immke joins as Chief Scientific Officer and Jonathan…
Sequana Medical to Host a Key Opinion Leader Webinar on “The Impact of Liver Ascites on Patients and Healthcare Systems and the potential of alfapump® therapy in NASH-related ascites”
Live webinar with Dr. Vargas and Dr. Knuttinen on 15 July 2021 at 4 pm…
Lyell Immunopharma Announces Pricing of Initial Public Offering
SOUTH SAN FRANCISCO, Calif., June 16, 2021 (GLOBE NEWSWIRE) — Lyell Immunopharma, Inc. (Lyell), (Nasdaq:…
C4 Therapeutics Announces Pricing of Public Offering
WATERTOWN, Mass., June 16, 2021 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a…
argenx announces publication of Phase 3 ADAPT trial results of efgartigimod for the treatment of generalized myasthenia gravis in The Lancet Neurology
Results from ADAPT showed treatment with efgartigimod provided clinically meaningful improvements in strength and quality…
23andMe Successfully Closes its Business Combination with VG Acquisition Corp.
Combined Company to Trade on Nasdaq Under Ticker “ME” Commencing June 17 SUNNYVALE, Calif. and…
Medexus Revenue Increases 43.5% to a Record US$79.7 Million for Fiscal 2021
Transformative licensing agreement for treosulfan in the U.S. completed February 2, 2021 Cash and cash…
Biogen Announces Topline Results From Phase 2 Study of Gosuranemab, an Anti-Tau Antibody, for Alzheimer’s Disease
CAMBRIDGE, Mass., June 16, 2021 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced topline results…
NexImmune to Present at the Raymond James 2021 Human Health Innovation Conference
GAITHERSBURG, Md., June 16, 2021 (GLOBE NEWSWIRE) — NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company…
Thomas P. Slavin, M.D., Named Chief Medical Officer for Myriad Genetics
Dr. Slavin Brings Deep Clinical, Academic and Industry Experience to New Role SALT LAKE CITY,…
Bioventus to Release Second Quarter of Fiscal Year 2021 Financial Results on August 10, 2021
DURHAM, N.C., June 16, 2021 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the…
Satsuma Pharmaceuticals Announces Positive Pharmacokinetic, Tolerability and Safety Results From Phase 1 Trial of STS101 at Multiple Dose Strengths
– All three dose strengths of STS101, administered with improved 2nd-generation nasal delivery device were…
Tarsus Pharmaceuticals, Inc. Initiates Phase 1 Callisto Trial of TP-05, a Novel, Oral, Non-Vaccine Therapeutic for the Prevention of Lyme Disease
More than 30 million Americans at risk for Lyme disease exposure, which can result in…
Collegium Announces Publication of Real-World Data in Journal of Pain Research
STOUGHTON, Mass., June 16, 2021 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical…
Evelo Biosciences Announces Grant of Inducement Award
CAMBRIDGE, Mass., June 16, 2021 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq: EVLO), a clinical…
Novan Announces Proposed Public Offering of Common Stock
DURHAM, N.C., June 16, 2021 (GLOBE NEWSWIRE) — Novan, Inc. (the “Company” or “Novan”) (NASDAQ:…
On substantial participation
JSC Olainfarm has received announcements on substantial participation from Anna EmÄ«lija Maligina, SIA “OLMAFARM” and SIA…
Better Choice Announces Offering of Common Stock Concurrent With Uplisting to the NYSE American Stock Exchange
NEW YORK, June 16, 2021 (GLOBE NEWSWIRE) — Better Choice Company (OTCQX: BTTR) (“Better Choice”),…
Kane Biotech launches 2021 business update series
Premiere episode “The Fundamentals” available now WINNIPEG, Manitoba, June 16, 2021 (GLOBE NEWSWIRE) — Kane…